SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001169245-21-000110
Filing Date
2021-11-09
Accepted
2021-11-09 20:45:00
Documents
4
Period of Report
2021-11-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_163650867003086.html 3  
1 FORM 3 wf-form3_163650867003086.xml 3 1768
2 BIRCHALL - POA HTM jonathanbirchallpoa11032.htm EX-24 962
3 BIRCHALL POA 1 JPG jonathanbirchallpoa11032001.jpg GRAPHIC 248378
4 BIRCHALL POA JPG 2 jonathanbirchallpoa11032002.jpg GRAPHIC 64466
  Complete submission text file 0001169245-21-000110.txt   435485
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Issuer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PHASEBIO PHARMACEUTICALS, INC. 1 GREAT VALLEY PARKWAY, SUITE 30 MALVERN PA 19355
Business Address
Birchall Jonathan (Reporting) CIK: 0001892776 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38697 | Film No.: 211394025